Terns Pharmaceuticals, Inc.
TERN
Peringkat dalam Saham
#3565
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Harga Saham
$52.95
Terakhir disinkronkan: 2026-05-15
Kapitalisasi Pasar
$4.77B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
514.27%
Negara
US
Perdagangan Terns Pharmaceuticals, Inc. (TERN)
Kategori
Healthcare
Rasio P/S untuk Terns Pharmaceuticals, Inc. (TERN)
Rasio P/S per October 2026 TTM: 0.00
Menurut laporan keuangan dan harga saham terbaru dari Terns Pharmaceuticals, Inc., rasio P/S saat ini (TTM) adalah 0.00. Pada akhir 2023, rasio P/S perusahaan adalah 0.00.
Riwayat rasio P/S untuk Terns Pharmaceuticals, Inc. dari 2018 hingga 2026
Rasio P/S pada akhir setiap tahun
| Tahun | Rasio P/S | Mengubah |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2024 | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | -100.00% |
| 2021 | 178.65 | 0.00% |
| 2020 | 0.00 | 0.00% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | 0.00% |
Rasio P/S untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/S | Perbedaan Rasio P/S | Negara |
|---|---|---|---|
| 10.02 | - |
US
|
|
| 40.55 | - |
US
|
|
| 3.96 | - |
AU
|
|
| - | - |
CH
|
|
| 10.15 | - |
NL
|
